Orbimed Advisors - BIOHAVEN PHARMACTL HLDG CO L ownership

Back to all holdings Add to watchlist

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 2 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2023. The put-call ratio across all filers is - and the average weighting 6.6%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
Orbimed Advisors ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$25,815,000
-75.4%
170,769
-76.3%
0.48%
-74.8%
Q2 2022$104,770,000
+22.9%
719,0340.0%1.90%
+37.3%
Q1 2022$85,256,000
+6519.3%
719,034
+1338.1%
1.38%
+8537.5%
Q1 2018$1,288,000–50,000–0.02%–
 Download
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q3 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 490,422$12,755,87613.24%
FNY Investment Advisers, LLC 30$00.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders